  |  
				 |  
				
				| 
                 
                  
                            
                            
                             
                             
							 
							  
                  
                
          
		  
		  
		  
				| 
					Interesting ECG
					[April 17, 09:15-10:45 Rm.103]
				 | 
				 | 
			 
			
				| Chairpersons | 
				노태호, 조정관 | 
				 
			
				| Speakers | 
				김유리/가톨릭의대, 문희선/한림의대, 박준범/연세의대, 신승용/중앙의대, 엄재선/연세의대, 조영진/서울의대 | 
				 
		  
        
			
				| 
					Myocardial Infarction 1
					[April 17, 09:30-10:45 Rm.104]
				 | 
				 | 
			 
            
				| How to Analyze and Write Good Papers from a Big Registry Data | 
			 
			
				| Chairpersons | 
				김종진, 조명찬 | 
			 
            
				| Panel | 
				강현재, 나득영, 정진옥, 황진용 | 
			 
			
				| 09:30-09:45 | 
				Sharing Experiences: How to Analysis Data from KORMI/KAMIR  | 
				나승운/고려의대 | 
			 
            
				| 09:45-10:10 | 
				Analysis of HIRA-Claim Data | 
				이중엽/서울의대 | 
			 
            
				| 10:10-10:35 | 
				Dealing with Confounding in the Analysis of Registry Data | 
				윤성철/울산의대 | 
			 
            
				| 10:35-10:45 | 
				Discussion | 
			 
		   
        
          
        
        
        
			
				| 
					Imaging 1
					[April 17, 09:30-10:45 Rm.205]
				 | 
				 | 
			 
            
				| Screening Value of Imaging of High-Risk Subjects for Cardiovascular Disease | 
			 
			
				| Chairpersons | 
			  조인호, 김태훈 | 
			 
            
				| Panel | 
			  박재형, 유승민, 원경숙 | 
			 
			
				| 09:30-09:50 | 
				Coronary CT and Calcium CT ? The Resolution for Cardiovascular Screening  | 
				최상일/서울의대 | 
			 
            
				| 09:50-10:10 | 
				Echocardiography for Screening in Preoperative and High-Risk Subjects | 
				김은경/성균관의대 | 
			 
            
				| 10:10-10:30 | 
				SPECT or PET for Cardiovascular Screening in High-Risk Subjects  | 
				팽진철/서울의대 | 
			 
            
				| 10:30-10:45 | 
			  Discussion | 
			 
		   
        
         
		   
        
          
        
        
			
				| 
					CHF 2
					[April 17, 10:55-12:20 Rm.201]
				 | 
				 | 
			 
            
				| Heart Failure : Factors for the Progression and Reversal of Clinical Course | 
			 
			
				| Chairpersons | 
			  김재중, 최동주 | 
			 
            
				| Panel | 
			  강석민, 김동수, 김용진, 양동헌, 유병수 | 
			 
			
				| 10:55-11:10 | 
				Myocardial Ischemia in HFrEF | 
				한성우/한림의대 | 
			 
            
				| 11:10-11:25 | 
				Reverse Remodeling of Heart Failure  | 
				김계훈/전남의대 | 
			 
            
				| 11:25-11:40 | 
				Atrial Fibrillation and Decompensated Heart Failure  | 
				김성환/가톨릭의대 | 
			 
             
				| 11:40-12:05 | 
				Keynote Lecture: Heart Failure: The Recent Advances | 
				John J.V. Mcmurray/ Glasgow Univ., UK | 
			 
            
				| 12:05-12:20 | 
			  Discussion | 
			 
		   
        
         
			
				| 
					Imaging 2
					[April 17, 10:55-12:20 Rm.205]
				 | 
				 | 
			 
            
				| Recent Controversial Issues in Cardiovascular Perfusion Imaging | 
			 
			
				| Chairpersons | 
				최연현, 송재관 | 
			 
            
				| Panel | 
				강원준,이상철,허진 | 
			 
			
				| 10:55-11:20 | 
				Myocardial CT Perfusion: The New One-Stop Shop for Ischemic Heart Disease | 
				양동현/울산의대 | 
			 
            
				| 11:20-11:45 | 
				The Prime for MR Cardiac Perfusion   | 
				추기석/부산의대 | 
			 
            
				| 11:45-11:55 | 
				Rebuttal by Presenter 1 | 
			 
             
				| 11:55-12:05 | 
				Rebuttal by Presenter 2 | 
			 
            
				| 12:05-12:20 | 
				Discussion | 
			 
		   
        
        
		
			
				| 
					Scientific Session 1 [Boryung]
					[April 17, 12:30-13:10 Rm.103]
				 | 
				 | 
			 
            
				| Optimal BP Control: The Latest ARB | 
			 
			
				| Chairpersons | 
				김권삼, 채성철 | 
			 
			
				| 12:30-12:50 | 
				Effect of RAS Inhibition in Metabolic Syndrome: The Korean Perspective from K-Mets Study | 
				정우백/가톨릭의대 | 
			  	
			
				| 12:50-13:10 | 
				The Efficacy and Safety of the Combination of Fimasartan/Amlodipine in Patients with Essential HTN | 
				한성욱/계명의대 | 
			 
					
		   
        
           
        
         
			
				| 
					Scientific Session 3 [Boehringer Ingelheim]
					[April 17, 12:30-13:10 Rm.205]
				 | 
				 | 
			 
			
				| Chairpersons | 
				김효수, 신동구 | 
			 
           
				| Reassuring Real World Data of Dabigatran and Thromboembolic Protection Across Indications | 
			 
			
				| 12:30-12:50 | 
				Real World Treatment Experience with Dabigatran Etexilate for Stroke Prevention in AF  | 
				박형욱/전남의대 | 
			 
			
				| 12:50-13:10 | 
				Dabigatran Etexilate for the Treatment of Acute DVT/PE and Prevention of Recurrence | 
				고영국/연세의대 | 
			 			
		   
        
        
		
			
				| 
					Suh, Soon-Kyu Memorial Lecture
					[April 17, 14:30-15:15 Rm.103]
				 | 
				 | 
			 
            
				| Chairperson | 
			  김영조 | 
			 
			
				| 14:30-15:10 | 
				Diet, Herbs and Supplements: What Works | 
				C. Noel Bairey Merz/ Cedars-Sinai Medical Center, USA | 
			 
           
				| 15:10-15:15 | 
			  Discussion | 
			 
		   
        
        
			
				| 
					Plenary Session
					[April 17, 15:15-16:00 Rm.103]
				 | 
				 | 
			 
			
				| Chairperson | 
			  오병희 | 
			 
			
				| 15:15-15:55 | 
				ARNI: A True Paradigm Shift in HF Management | 
				John McMurray/ Glasgow Univ., UK | 
			 
           
				| 15:55-16:00 | 
			  Discussion | 
			 
		   
        
        
         
		  
        
        
         
			
				| 
					Allied Professional 1
					[April 17, 16:15-17:45 Rm.201]
				 | 
				 | 
			 
            
				| Cardiac Arrhythmia Diagnostics | 
			 
			
				| Chairpersons | 
			  최현철, 고경정 | 
			 
            
			  | 16:15-16:45 | 
			  SVT vs. VT Differential Diagnosis | 
				박종성/동아의대 | 
			 
            
				| 16:45-17:15 | 
				Tilt-Table Test : Protocols and Diagnostic Efficacy | 
				박정왜/삼성서울병원 | 
			 
            
				| 17:15-17:45 | 
				Radiation Exposure in the Cath Lab-Safety and Precautions  | 
                강준원/고대안암병원 | 
			 
            
		   
        
        
        
			
				| 
					Women's Heart Disease
					[April 17, 16:15-17:45 Rm.205]
				 | 
				 | 
			 
            
				| Women and Ischemic Heart Disease | 
			 
			
				| Chairpersons | 
			  심완주, 김순길 | 
			 
            
				| Panel | 
			  신미승, 손일석, 홍경순 | 
			 
			
				| 16:15-16:45 | 
				Detection, Diagnosis and Management | 
				C. Noel Bairey Merz/Cedars-Sinai Medical Center, USA | 
			 
            
				| 16:45-17:05 | 
				Pathophysiology : Vasospasm and Microvascular Angina | 
				박성미/고려의대 | 
			 
            
				| 17:05-17:25 | 
				Gender Specific Risk Factors for Ischemic Heart Disease  | 
                김학령/서울의대 | 
			 
            
				| 17:25-17:45 | 
			  Discussion | 
			 
		   
        
        
           
        
        
          
            
            
            
			
				| 
					Congenital Heart Disease 1
					[April 18, 08:30-10:00 Rm.203]
				 | 
				 | 
			 
            
				| Natural and Unnatural History of Adults with Congenital Heart Disease | 
			 
			
				| Chairpersons | 
			  노정일, 고재곤 | 
			 
            
				| Panel | 
			  김계훈, 김성호, 배은정, 송종민 | 
			 
			
				| 08:30-08:50 | 
				Prevalence of Adult Congenital Heart Disease (ACHD)  | 
				정조원/연세의대 | 
			 
            
				| 08:50-09:10 | 
				Trends in Survival and Mortality in Current Era  | 
				길홍량/충남의대 | 
			 
            
				| 09:10-09:30 | 
				Cardiopulmonary Variables During Exercise in Adult Patients with Congenital Heart Disease | 
                Hideo Ohuchi/National Cardiovascular Center, Japan | 
			 
             
				| 09:30-09:50 | 
				Quality of Life in Adults with CHD  | 
                박승우/성균관의대 | 
			 
            
				| 09:50-10:00 | 
			  Discussion | 
			 
		   
        
        
           
        
        
		  
        
          
        
        
        
          
        
         
		 
			
				| 
					Scientific Session 4 [Bayer]
					[April 18, 12:00-12:40 Rm.103]
				 | 
				 | 
			 			
            
				| Rivaroxaban in Cardiology: Current Practice and Exploring Future Directions | 
			 
			
				| Chairpersons | 
				김영대, 이문형 | 
			 
			
				| 12:00-12:20 | 
				New Trends and Treatment of Novel Oral Anticoagulants in AF Patients Undergoing Cardioversion | 
				박희남/연세의대 | 
			 
			
				| 12:20-12:40 | 
				Simple to Start, Easy to Maintain for VTE Treatment | 
				김계훈/전남의대 | 
			 
			
		   
        
           
        
        
           
		 
		
			
				| 
					Health Policies on CVD
					[April 18, 13:00-13:50 Rm.201]
				 | 
				 | 
			 
            
				| Health Policies on CVD: What's New? | 
			 
			
				| Chairpersons | 
			  조명찬, 김효수 | 
			             
			
            
				| 13:00-13:15 | 
				심뇌혈관종합대책: 10년간의 경과와 향후 계획 
				(National Action Plan to Prevent Heart Disease and Stroke: A Decade of Progress and Outlook for the Future) | 
				이재용/ 보건복지부 질병정책과 | 
			 
            
				| 13:15-13:30 | 
				심혈관질환예방을 위한 만성질환예방 및 관리사업의 성과와 숙제 (Community-Based Initiatives for CVD Prevention) | 
                정율원/ 질병관리본부 만성질환관리과 | 
			 
             
				| 13:30-13:45 | 
				CVD 예방관리를 위한 R&D (Prioritized Research Agenda for Evidence-Based CVD Prevention and Care)  | 
                박현영/ 국립보건연구원 심혈관희귀질환과 | 
			            
		   
        
        
         
		  
        
        
        
		
			
				| 
					Mobile Healthcare Knocks on Your Clinic
					[April 18, 14:00-15:30 Rm.201]
				 | 
				 | 
			 
            
				| Mobile Healthcare Knocks on Your Clinic | 
			 
			
				| Chairpersons | 
			  김영조, 박승우 | 
			 
			
				| 14:00-14:15 | 
				모바일헬스케어 소개 | 
				정지훈/경희사이버대 | 
			 
            
				| 14:15-14:30 | 
				모바일헬스케어의 기술 | 
				박은성/ 삼성전자 종합기술원 | 
			 
            
				| 14:30-14:45 | 
				모바일헬스케어의 경험 | 
                육태선/ SK텔레콤 신사업추친단 | 
			 
			
				| 14:45-15:00 | 
				모바일헬스케어 정책 | 
                구혁채/ 미래창조과학부 창조융합기획과 | 
			 
			
				| 15:00-15:15 | 
				눈앞에 닥친 모바일 헬스케어   | 
                박승우/성균관의대 | 
			 
			
				| 15:15-15:30 | 
			  Discussion | 
			 
            
		   
        
        
        
          
        
        
         
		   
        
        
        
			
				| 
					Basic Research 2
					[April 18, 15:45-17:15 Rm.201]
				 | 
				 | 
			 
            
				| Signaling Mechanisms | 
			 
			
				| Chairpersons | 
			  오구택, 박현영 | 
			 
            
				| Panel | 
			  임병관, 조현재, 한승환 | 
			 
			
			
				| 15:45-16:05 | 
				Tetrahydrobiopterin-Induced Cardioprotective Signaling Mechanism  | 
				한진/인제의대  | 
			 
            
				| 16:05-16:25 | 
				Posttranslational Modification of Histone Deacetylase 2 in Cardiac Hypertrophy  | 
				국현/전남의대 | 
			 
            
				| 16:25-16:45 | 
				Role of Formyl Peptide Receptor 2 in Therapeutic Angiogenesis | 
                김재호/부산의대 | 
			 
             
				| 16:45-17:05 | 
				ROS Signaling in Atherosclerosis via Impaired Autophagy | 
                오구택/이화여대 | 
			 
            
				| 17:05-17:15 | 
			  Discussion | 
			 
		   
        
        
        
			
				| 
					Congenital Heart Disease 4
					[April 18, 15:45-17:15 Rm.203]
				 | 
				 | 
			 
            
				| New Medication & Treatment | 
			 
			
				| Chairpersons | 
			  김용진(서울의대, 흉부외과), 김남수 | 
			 
            
				| Panel | 
			  송민섭, 송진영, 심우섭, 조준용, 최재영 | 
			 
			
				| 15:45-16:05 | 
				New Cardiovascular Drugs for Pediatric Heart Failure | 
				하기수/고려의대 | 
			 
            
				| 16:05-16:25 | 
				New Drugs for Pulmonary Hypertension 
  | 
				김기범/서울의대 | 
			 
			
				| Pros & Cons : Late Failure of Fontan Circulation    | 
			 
            
				| 16:25-16:45 | 
				- Fontan Takedown, and Conversion to Two Ventricle | 
                이창하/세종병원 | 
			 
             
				| 16:45-17:05 | 
				- Heart Transplantation  | 
                박정준/울산의대 | 
			 
            
				| 17:05-17:15 | 
			  Discussion | 
			 
		   
        
        
			
				| 
					Vascular Disease
					[April 18, 15:45-17:15 Rm.205]
				 | 
				 | 
			 
            
				| Contribution of Arterial Stiffness to the Development of Hypertension: from Bench to Bedside | 
			 
			
				| Chairpersons | 
			  정진원, 박정배 | 
			 
			
				| 15:45-16:15 | 
				Aortic Stiffness, Blood Pressure Progression and Incident Hypertension | 
				Boutouyrie Pierre/  HEGP Hopital Europeen, France | 
			 
            
				| 16:15-16:35 | 
				Can Exercise Reduce Arterial Stiffness in Hypertensives? | 
				제세영/서울시립대 | 
			 
            
				| 16:35-16:55 | 
				Vascular Calcification: A Novel Mechanism for Aortic Stiffness in Hypertension  | 
                김응주/고려의대 | 
			 
             
				| 16:55-17:15 | 
				Interplay of Inflammation and Oxidative Stress in Aortic Stiffening | 
                박성하/연세의대 | 
			 
		  
 
  
        
        
        
        
        
           
         
          
			
				| 
					KSE 1
					[April 17, 14:30-16:00 Rm.104]
				 | 
				 | 
			 
            
				| Issues & Updates in Valvular Heart Disease | 
			 
			
				| Chairpersons | 
				심완주, 채성철 | 
			 
			
				| 14:30-14:50 | 
				Bicuspid Aortic Valve: Pathogenesis & Clinical Significance | 
				송재관/울산의대 | 
			 
            
				| 14:50-15:10 | 
				Paradoxical Low Gradient Severe AS: Causes & Prognostic Implication | 
				김용진/서울의대 | 
			 
            
				| 15:10-15:30 | 
				Secondary Mitral Regurgitation: Severity Assessment & Management | 
                권준/인하의대 | 
			 
             
				| 15:30-15:50 | 
				Marfan Syndrome: Diagnosis & Management | 
                박승우/성균관의대 | 
			 
             
				| 15:50-16:00 | 
				Discussion | 
             
		   
        
        
        
			
				| 
					KSE 2
					[April 17, 16:15-17:45 Rm.103]
				 | 
				 | 
			 
            
				| Learning from Cases & Echocardiography | 
			 
			
				| Chairpersons | 
				 장경식, 신준한 | 
			 
            
				| Panel | 
				김신재, 서정숙, 최의영 | 
			 
			
				| 16:15-16:35 | 
				Mitral Valve Disease | 
				박태호/동아의대 | 
			 
            
				| 16:35-16:55 | 
				Aortic Valve Disease | 
				박성지/성균관의대 | 
			 
            
				| 16:55-17:15 | 
				Tricuspid Valve Disease | 
                홍그루/연세의대 | 
			 
             
				| 17:15-17:35 | 
				Infective Endocarditis | 
                강덕현/울산의대 | 
			 
             
				| 17:35-17:45 | 
				Discussion | 
             
		   
        
        
         
			
				| 
					KSE 3
					[April 18, 10:15-11:45 Rm.104]
				 | 
				 | 
			 
            
				| Issue & Updates in Myocardial & Pericardial Disease | 
			 
			
				| Chairpersons | 
				손대원, 김기식 | 
			 
			
				| 10:15-10:35 | 
				Cardiac Amyloidosis: Diagnostic Tools & Management | 
				이승표/서울의대 | 
			 
            
				| 10:35-10:55 | 
				Hypertrophic Cardiomyopathy: Differential Diagnosis & Management | 
				김우식/경희의대 | 
			 
            
				| 10:55-11:15 | 
				Tuberculous Pericarditis: Diagnosis & Management | 
                송종민/울산의대 | 
			 
             
				| 11:15-11:35 | 
				Constrictive Pericarditis: Transient & Reversible Constriction | 
                김계훈/전남의대 | 
			 
             
				| 11:35-11:45 | 
				Discussion | 
             
		   
        
        
        
			
				| 
					KSE 4
					[April 18, 14:00-15:30 Rm.205]
				 | 
				 | 
			 
            
				| Learning from Cases & Echocardiography | 
			 
			
				| Chairpersons | 
				박종춘, 윤호중 | 
			 
            
				| Panel | 
				김성환, 이선화, 최정현 | 
			 
			
				| 14:00-14:20 | 
				Hypertrophic Cardiomyopathy | 
				양동헌/경북의대 | 
			 
            
				| 14:20-14:40 | 
				Stress Cardiomyopathy | 
				한성우/한림의대 | 
			 
            
				| 14:40-15:00 | 
				Myocarditis/Myocardial Infiltration | 
                조구영/서울의대 | 
			 
             
				| 15:00-15:20 | 
				Pericardial Disease | 
                이상철/성균관의대 | 
			 
             
				| 15:20-15:30 | 
				Discussion | 
             
		  
 
  
        
        
        
                 
        
           
         
          
		  
				| 
					KSLA 1
					[April 17, 09:15-10:45 Rm.203] | 
				 | 
			 
            
				| Vascular Research in Cardiovascular Disease | 
			 
			
				| Chairpersons | 
				최영길, 김양하 | 
			 
            
				| Panel | 
				강신애, 김오연, 박성하, 임수, 조경현 | 
			 
			
				| 09:15-09:40 | 
				Immunosenescence and Vascular Aging | 
				신의철/한국과학기술원 | 
			 
            
				| 09:40-10:05 | 
				Role of PCSK9 in Uptake and Degradation of LDL Particles  | 
				박상욱/연세의대 | 
			 
            
				| 10:05-10:30 | 
				Metabolomic Profiling for the Metabolism and Atherogenesis | 
                황금숙/한국기초과학지원연구원 | 
			 
             
				| 10:30-10:45 | 
				Discussion | 
             
		   
        
        
        
			
				| 
					KSLA 2
					[April 17, 10:55-12:20 Rm.203]
				 | 
				 | 
			 
            
				| Metabolism and Brain | 
			 
			
				| Chairpersons | 
				신현호, 서홍석 | 
			 
            
				| Panel | 
				김용재, 박광열, 오구택, 이은정, 최성희 | 
			 
			
				| 10:55-11:20 | 
				Metabolic Actions of Rho-Kinase in Periphery and Brain | 
				Young-Bum Kim/Harvard Univ., USA | 
			 
            
				| 11:20-11:45 | 
				Possible Role of Low-dose PPAR-γ Agonist through LRP1 Regulation in Alzheimer’s Disease | 
				차봉수/연세의대 | 
			 
            
				| 11:45-12:10 | 
				The Role of Free Fatty Acid in Ischemic Stroke | 
                서우근/고려의대 | 
			 
             
				| 12:10-12:20 | 
				Discussion | 
             
		   
        
        
        
			
				| 
					KSLA 3
					[April 17, 14:30-16:00 Rm.203]
				 | 
				 | 
			 
            
				| Update of Cholesterol Treatment Guidelines  | 
			 
			
				| Chairpersons | 
				김치정, 박경수 | 
			 
            
				| Panel | 
				김대중, 김병진, 김용석, 송기호, 이상학 | 
			 
			
				| 14:30-14:55 | 
				Review of Updated Korean Cholesterol Treatment Guidelines and Others | 
				김상현/서울의대 | 
			 
            
				| 14:55-15:20 | 
				Should We Apply Subclinical Atherosclerosis as a Marker for CVD Risk? | 
				한기훈/울산의대 | 
			 
            
				| 15:20-15:45 | 
				CVD Risk Calculators: What Are Their Positions in the Clinical Practice? | 
                정창희/울산의대 | 
			 
             
				| 15:45-16:00 | 
				Discussion | 
             
		   
        
        
        
			
				| 
					KSLA 4
					[April 17, 16:15-17:45 Rm.203]
				 | 
				 | 
			 
            
				| Special Debate Session: "A Patient with Type 2 Diabetes without Any History of Cardiovascular Disease and Already on Statin with LDL-C < 100 mg/dL, but Still High TG and Low HDL-C. What's Next?"  | 
			 
			
				| Chairpersons | 
				이문규 | 
			 
            
				| Panel | 
				김재택, 김혜진, 서지아, 조상호, 최소연 | 
			 
			
				| 16:15-16:25 | 
				Introduction | 
				이문규/성균관의대 | 
			 
            
				| 16:25-16:50 | 
				Increase the Statin Dosage | 
				성기철/성균관의대 | 
			 
            
				| 16:50-17:15  | 
				Add Fibrates | 
                김성래/가톨릭의대 | 
			 
             
				| 17:15-17:40 | 
				Discussion | 
             
             
				| 17:40-17:45  | 
				Voting and Conclusion | 
             
		   
		  
         
          
		  
				| 
					KSIC 1
					[April 18, 08:30-9:50 Rm.103] | 
				 | 
			 
            
				| For Young Interventionist : Basic Techniques for Coronary Intervention | 
			 
			
				| Chairpersons | 
				양주영, 채인호 | 
			 
            
				| Panel | 
				김기석, 박종선, 박훈준, 전국진, 홍영준 | 
			 
			
				| 08:30-08:42 | 
				Puncture Technique and Hemostasis (Femoral and Radial) | 
				김상민/충북의대 | 
			 
            
				| 08:42-08:54 | 
				Selection of Guiding Catheter According to Artery | 
				신동호/연세의대 | 
			 
            
				| 08:54-09:06 | 
				Selection of Guidewire According to Lesion | 
                김승환/을지의대 | 
			 
			 
				| 09:06-09:18 | 
				Optimal Stenting for Bifurcated Lesion | 
                송영빈/성균관의대 | 
			 
             
				| 09:18-09:30 | 
				Optimal Stenting for Calcified Tortuous Lesion | 
                윤혁준/계명의대 | 
			 
             
				| 09:30-09:50 | 
				Discussion | 
             
		   
        
        
         
			
				| 
					KSIC 2
					[April 18, 10:15-11:45 Rm.103]
				 | 
				 | 
			 
            
				| How Can We Decrease Infarction Size? | 
			 
			
				| Chairpersons | 
				안태훈, 김병옥 | 
			 
            
				| Panel | 
				강웅철, 강현재, 권기환, 유승기, 윤영원 | 
			 
			
				| 10:15-10:35 | 
				Ischemic Injury and Reperfusion Injury  | 
				서정원/서울의대 | 
			 
            
				| 10:35-10:55 | 
				Drug Therapy | 
				이장훈/경북의대 | 
			 
            
				| 10:55-11:15 | 
				Interventional Treatment | 
                이봉기/강원의대 | 
			 
             
				| 11:15-11:35 | 
				Cell and Future Therapy | 
                배장환/충북의대 | 
			 
             
				| 11:35-11:45 | 
				Discussion | 
             
		   
        
        
        
			
				| 
					KSIC 3
					[April 18, 14:00-15:30 Rm.104]
				 | 
				 | 
			 
            
				| Limitations ; What You Have to Know | 
			 
			
				| Chairpersons | 
				탁승제, 김두일 | 
			 
            
				| Panel | 
				구본권, 김병극, 안영근, 이재환, 임영효 | 
			 
			
				| 14:00-14:17 | 
				Limitation of CAG, What You Have to Know | 
				채제건/전북의대 | 
			 
            
				| 14:17-14:34 | 
				Limitation of IVUS, What You Have to Know | 
				이봉렬/대구파티마병원 | 
			 
            
				| 14:34-14:51 | 
				Limitation of OCT, What You Have to Know | 
                최소연/아주의대 | 
			 
             
				| 14:51-15:08 | 
				Limitation of FFR, What You Have to Know | 
                도준형/인제의대 | 
			 
             
				| 15:08-15:30 | 
				Discussion | 
             
		  
 
  
        
        
        
			
				| 
					KSIC 4
					[April 18, 15:45-17:15 Rm.103]
				 | 
				 | 
			 
            
				| What Is OMT (Optimal Medical Therapy) in Real World Practice | 
			 
			
				| Chairpersons | 
				정명호, 박헌식 | 
			 
            
				| Panel | 
				김상현, 나득영, 배장호, 주형준, 허승호 | 
			 
			
				| 15:45-16:02 | 
				How to Treat a Patient with Silent Nonobstructive Coronary Artery Disease in Coronary CT | 
				신상훈/일산병원 | 
			 
            
				| 16:02-16:19 | 
				How to Treat a Patient Intolerant to Aspirin After PCI: Short-Term and Long-Term Therapy | 
				한주용/성균관의대 | 
			 
            
				| 16:19-16:36 | 
				How to Treat a Patient Intolerant to Moderate Intensity Statin Who Is Proven ASCVD | 
                윤경호/원광의대 | 
			 
             
				| 16:36-16:53 | 
				How to Treat a Patient without Chest Pain After PCI ; Beta-Blocker First or RAS Inhibitor First? | 
                양태현/인제의대 | 
			 
             
				| 16:53-17:15 | 
				Discussion | 
             
		   
        
        
        
                
                 
                 |  
			 
		 |